Stay updated on CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page.

Latest updates to the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page
- ChecktodayChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check7 days agoChange DetectedAn NIH notice appears above the page, announcing updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2; the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check21 days agoChange DetectedThe site’s footer revision identifier changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedAccess to the study record has been replaced by a 403 Forbidden page, removing the detailed trial information and sponsor/location data from the page.SummaryDifference19%

- Check42 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0 in the footer, indicating a software update. No study content or navigation elements were altered.SummaryDifference0.0%

Stay in the know with updates to CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page.